Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
The Journal of Infectious Diseases|March 1, 1990
Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic ratsK M Wasan, K Vadiei, G Lopez-Berestein, et al.Pharmacotherapy|May 1, 1986
Acute hepatotoxicity after excessively high doses of carbamazepine on two occasionsD R Luke, M L Rocci, D H Schaible, et al.Clinical Pharmacology and Therapeutics|November 1, 1990
Validity of creatinine clearance estimates in the assessment of renal functionD R Luke, C E Halstenson, J A Opsahl, et al.Clinical Chemistry|August 1, 1987
Improved liquid-chromatographic assay of labetalol in plasmaD R Luke, G R Matzke, J T Clarkson, et al.Research Communications in Chemical Pathology and Pharmacology|October 1, 1986
Lack of pharmacodynamic interaction between pentoxifylline and warfarin in the ratD R Luke, M P O'Donnell, W F Keane, et al.Journal of Pharmaceutical Sciences|March 1, 1992
Pharmacokinetics of cyclosporine in bone marrow transplantation: longitudinal characterization of drug in lipoprotein fractionsD R Luke, L J Brunner, G Lopez-Berestein, et al.The Journal of Infectious Diseases|July 1, 1990
Enhancement of the treatment of experimental candidiasis with vascular decongestantsD R Luke, K M Wasan, T J McQueen, et al.Journal of Clinical Pharmacology|March 1, 1995
Influence of human serum albumin content in formulations on the bioequivalency of interferon alfa-2a given by subcutaneous injection in healthy male volunteersJ Zhi, S B Teller, H Satoh, et al.Antimicrobial Agents and Chemotherapy|February 1, 1990
Pentoxifylline in amphotericin B toxicity rat modelK M Wasan, K Vadiei, G Lopez-Berestein, et al.European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1989
Cyclosporine pharmacokinetics and effect in the type I diabetic rat modelL J Brunner, L V Iyer, K Vadiei, et al.Pageof 7